Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Harvard Business School
Chinese Patent Office
Moodys
QuintilesIMS
Accenture
Cipla
Deloitte
Covington

Generated: January 15, 2019

DrugPatentWatch Database Preview

Cnty Line Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for CNTY LINE PHARMS, and what generic alternatives to CNTY LINE PHARMS drugs are available?

CNTY LINE PHARMS has seventeen approved drugs.

There is one US patent protecting CNTY LINE PHARMS drugs.

There are forty-one patent family members on CNTY LINE PHARMS drugs in thirty-four countries.

Summary for Cnty Line Pharms
International Patents:41
US Patents:1
Tradenames:14
Ingredients:11
NDAs:17

Drugs and US Patents for Cnty Line Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-001 Oct 31, 1985 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Cnty Line Pharms FENOFIBRATE (MICRONIZED) fenofibrate CAPSULE;ORAL 207805-001 Nov 16, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Cnty Line Pharms FENOFIBRATE (MICRONIZED) fenofibrate CAPSULE;ORAL 207805-002 Nov 16, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Cnty Line Pharms LIDEX fluocinonide SOLUTION;TOPICAL 018849-001 Apr 6, 1984 AT RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Cnty Line Pharms UREX methenamine hippurate TABLET;ORAL 016151-001 Approved Prior to Jan 1, 1982 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Cnty Line Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cnty Line Pharms LIDEX fluocinonide OINTMENT;TOPICAL 016909-002 Approved Prior to Jan 1, 1982 4,017,615 ➤ Try a Free Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-001 Oct 31, 1985 4,642,384 ➤ Try a Free Trial
Cnty Line Pharms TRANDATE labetalol hydrochloride TABLET;ORAL 018716-001 May 24, 1985 4,066,755 ➤ Try a Free Trial
Cnty Line Pharms LIDEX fluocinonide CREAM;TOPICAL 016908-002 Approved Prior to Jan 1, 1982 3,592,930 ➤ Try a Free Trial
Cnty Line Pharms TRANDATE labetalol hydrochloride TABLET;ORAL 018716-003 Aug 1, 1984 4,012,444 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Premature patent expirations for CNTY LINE PHARMS

Expiration due to failure to pay maintenance fee

Patent Number Expiration Date
➤ Try a Free Trial ➤ Try a Free Trial
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Chinese Patent Office
Deloitte
Julphar
Colorcon
Express Scripts
McKesson
QuintilesIMS
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.